Ubs Group Ag Kala Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$0.25 - $11.7 $2,581 - $120,790
10,324 Added 16.43%
73,144 $15,000
Q2 2022

Aug 10, 2022
BUY
$0.3 - $1.31 $13,386 - $58,452
44,620 Added 245.16%
62,820 $19,000
Q1 2022

May 16, 2022
SELL
$0.61 - $1.84 $10,077 - $30,398
-16,521 Reduced 47.58%
18,200 $25,000
Q4 2021

Feb 14, 2022
BUY
$1.16 - $2.74 $29,088 - $68,708
25,076 Added 259.99%
34,721 $42,000
Q3 2021

Nov 15, 2021
SELL
$2.62 - $5.43 $878,816 - $1.82 Million
-335,426 Reduced 97.2%
9,645 $25,000
Q2 2021

Aug 13, 2021
BUY
$5.06 - $8.15 $1.46 Million - $2.35 Million
287,832 Added 502.86%
345,071 $1.83 Million
Q1 2021

May 12, 2021
BUY
$6.24 - $9.58 $319,619 - $490,697
51,221 Added 851.13%
57,239 $386,000
Q4 2020

Feb 11, 2021
BUY
$6.28 - $8.79 $22,721 - $31,802
3,618 Added 150.75%
6,018 $40,000
Q3 2020

Nov 12, 2020
SELL
$7.5 - $11.11 $84,472 - $125,131
-11,263 Reduced 82.43%
2,400 $18,000
Q2 2020

Jul 31, 2020
SELL
$8.33 - $13.79 $23,732 - $39,287
-2,849 Reduced 17.25%
13,663 $144,000
Q1 2020

May 01, 2020
SELL
$3.83 - $8.79 $59,943 - $137,572
-15,651 Reduced 48.66%
16,512 $145,000
Q4 2019

Feb 14, 2020
BUY
$3.36 - $4.81 $61,215 - $87,633
18,219 Added 130.66%
32,163 $119,000
Q3 2019

Nov 14, 2019
BUY
$3.57 - $6.58 $32,287 - $59,509
9,044 Added 184.57%
13,944 $53,000
Q2 2019

Aug 14, 2019
BUY
$4.93 - $8.8 $14,790 - $26,400
3,000 Added 157.89%
4,900 $31,000
Q1 2019

May 14, 2019
SELL
$5.19 - $8.97 $9,788 - $16,917
-1,886 Reduced 49.82%
1,900 $16,000
Q4 2018

Feb 14, 2019
BUY
$4.29 - $9.94 $14,096 - $32,662
3,286 Added 657.2%
3,786 $19,000
Q2 2018

Aug 14, 2018
SELL
$13.3 - $17.49 $10,560 - $13,887
-794 Reduced 61.36%
500 $7,000
Q1 2018

May 15, 2018
BUY
$12.26 - $18.98 $15,864 - $24,560
1,294 New
1,294 $21,000
Q4 2017

Feb 14, 2018
SELL
$13.68 - $23.17 $32,148 - $54,449
-2,350 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$19.86 - $26.53 $46,671 - $62,345
2,350
2,350 $54,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $7.83M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email